Colony »

Biomarin Pharmaceutical shares owned by Colony

Quarter-by-quarter ownership of Biomarin Pharmaceutical shares owned by Colony from 13F filings

Historical chart of Colony investment in Biomarin Pharmaceutical

Tip: Access up to 7 years of quarterly data

All positions including Biomarin Pharmaceutical held by Colony consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Biomarin Pharmaceutical by Colony

Quarter filed Position value Share count Share price at filing
2025-12-31 $3.3M 3.4M 0.95

More positions owned by Colony

Apple (AAPL)
Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Select Sector Spdr Tr State Street Tec (XLK)
Dimensional Etf Trust Us Core Equity 2 (DFAC)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Amazon (AMZN)
Ishares Tr Core S&p500 Etf (IVV)
Alphabet Cap Stk Cl C (GOOG)
Alphabet Cap Stk Cl A (GOOGL)
Valued Advisers Tr Kovitz Core Eqt (EQTY)
Vanguard World Inf Tech Etf (VGT)
JPMorgan Chase & Co. (JPM)
Ishares Tr Core S&p Ttl Stk (ITOT)

View all positions for Colony

Top funds holding Biomarin Pharmaceutical

Tenor Capital Management
Lazard Asset Management
BlackRock
Man Group
Capstone Investment Advisors
MacKay Shields
Opti Capital Management
Millennium Management
Verition Fund Management
Oaktree Capital Management
Victory Capital Management
Thrivent Financial for Lutherans
CNH Partners
DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main
Jpmorgan Chase & Co

View all funds holding Biomarin Pharmaceutical